FDA Clears GE HealthCare’s AI-Powered Auto-Contouring Tool, Revolutionizing Radiation Therapy Planning
The FDA has granted clearance to GE HealthCare’s AI-enabled auto-contouring software, a groundbreaking technology designed to improve the accuracy and efficiency of radiation therapy planning. This innovative tool has the potential to revolutionize the field of radiation oncology, enabling healthcare professionals to provide more effective and personalized treatment for cancer patients. With its clearance, GE HealthCare’s AI-powered software is poised to make a significant impact on the future of cancer care.